Currently, there are no deposited reference standard preparations available for the mucin proteins MUC4 or MUC5AC, which are important biomarkers for pancreatic cancer, or for the heavily utilized CA19-9 biomarker that occurs on mucin proteins and is approved for monitoring of gastrointestinal (GI) malignancies. This evidence concerns the gene MUC5AC and pancreatic neoplasm.